131 filings
8-K
CDTX
Cidara Therapeutics Inc
20 May 24
Departure of Directors or Certain Officers
4:04pm
8-K
CDTX
Cidara Therapeutics Inc
15 May 24
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:22pm
8-K
CDTX
Cidara Therapeutics Inc
3 May 24
Other Events
8:00am
8-K/A
CDTX
Cidara Therapeutics Inc
29 Apr 24
Entry into a Material Definitive Agreement
4:57pm
8-K
CDTX
Cidara Therapeutics Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:09pm
8-K
41rg0s76
24 Apr 24
Entry into a Material Definitive Agreement
4:07pm
8-K
fntm2s5sbmv0iaoz5s
22 Apr 24
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
5:18pm
8-K
ka4omnhc48i iwszezi0
16 Apr 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:02am
8-K
5y0ds n14y40d9tya
5 Apr 24
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
3cw1261ta5rux
9 Feb 24
Other Events
8:00am
8-K
m4pwa
22 Dec 23
Other Events
7:33am
8-K
k9ywketafil4ylq5p
17 Nov 23
Other Events
1:22pm
8-K
dtmp0fol
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
g73gly
2 Nov 23
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:08pm
8-K
8mz6fj 2p7
13 Oct 23
Cidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1
10:36am
8-K
10qcekp ihr1ix32
21 Sep 23
Other Events
1:24pm
8-K
iz20melb4 ld37rpl
6 Sep 23
Cidara Therapeutics Announces Janssen’s Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza
8:05am
8-K
whllp2 wr8x9la
3 Aug 23
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:03pm
8-K
n9jlh wsxmq82hhxi21
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
9nmibfr8q j2
11 May 23
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm